Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients

International Journal of Oncology

Volumn 41, Issue 6, 2012, Pages 1950-1958

  Vral, A ^a   Magri, V ^b   Montanari, E ^c   Gazzano, G ^d   Gourvas, V ^e   Marras, E ^f   Perletti, Gianpaolo ^f  

^a GHENT UNIVERSITY   (Belgium)

^b PARKINSON INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Mellino Mellini Hospital Trust   (Italy)

^e General Hospital 'G Gennimatas'   (Greece)

^f UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Inflammation; Proliferative inflammatory atrophy; Prostate; Prostate atrophy; Prostate cancer; Prostatic intraepithelial neoplasia; Prostatitis

Indexed keywords

ARTICLE; ATROPHY; CANCER GRADING; CANCER RISK; CHRONIC PROSTATITIS; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLIFERATIVE INFLAMMATORY ATROPHY; PROSTATE BIOPSY; PROSTATE DISEASE; PROSTATE INFLAMMATION; PROSTATIC INTRAEPITHELIAL NEOPLASIA; QUESTIONNAIRE; SCORING SYSTEM;

ATROPHY; BIOPSY; HUMANS; MALE; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROSTATITIS; TOPOGRAPHY, MEDICAL;

EID: 84869852224     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1646     Document Type: Article

References (41)

1. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
2. Cheng I, Witte JS, Jacobsen SJ, et al: Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study. PLoS One 5: e8736, 2010.
3. Jafari S, Etminan M and Afshar K: Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis. Can Urol Assoc J 3: 323-330, 2009.
4. De Marzo AM, Platz EA, Sutcliffe S, et al: Inflammation in prostate carcinogenesis. Nat Rev Cancer 7: 256-269, 2007. (Pubitemid 46486616)
5. Perletti G, Montanari E, Vral A, Gazzano G, Marras E, Mione S and Magri V: Inflammation, prostatitis, proliferative inflammatory atrophy: ?Fertile ground' for prostate cancer development? Mol Med Rep 3: 3-12, 2010.
6. Kryvenko ON, Jankowski M, Chitale DA, Tang D, Rundle A, Trudeau S and Rybicki BA: Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer. Mod Pathol 25: 1023-1032, 2012
7. Davidsson S, Fiorentino M, Andrén O, et al: Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev 20: 2280-2287, 2011.
8. Putzi MJ and De Marzo AM: Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 56: 828-832, 2000.
9. Wang W, Bergh A and Damber JE: Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 69: 1378-1386, 2009.
10. Billis A, Freitas LL, Magna LA and Ferreira U: Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer? Int Braz J Urol 33: 355-360, 2007.
11. Brasil AA, Favaro WJ, Cagnon VH, Ferreira U and Billis A: Atrophy in specimens of radical prostatectomy: is there topographic relation to high grade prostatic intraepithelial neoplasia or cancer? Int Urol Nephrol 43: 397-403, 2011.
12. Billis A: Prostatic atrophy. Clinicopathological significance. Int Braz J Urol 36: 401-409, 2010.
13. Anton RC, Kattan MW, Chakraborty S and Wheeler TM: Postatrophic hyperplasia of the prostate: lack of association with prostate cancer. Am J Surg Pathol 23: 932-936, 1999. (Pubitemid 29360111)
14. Postma R, Schröder FH and van der Kwast TH: Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 65: 745-749, 2005. (Pubitemid 40523011)
15. Mikuz G, Algaba F, Beltran AL and Montironi R: Prostate carcinoma: atrophy or not atrophy that is the question. Eur Urol 52: 1293-1296, 2007. (Pubitemid 47446016)
16. Montironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L and Scarpelli M: Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Pract Urol 4: 321-332, 2007. (Pubitemid 46901993)
17. Sfanos KS and De Marzo AM: Prostate cancer and inflammation: the evidence. Histopathology 60: 199-215, 2012.
18. Yildiz-Sezer S, Verdorfer I, Schaefer G, Rogatsch H, Bartsch G and Mikuz G: Assessment of aberrations on chromosome 8 in prostatic atrophy. BJU Int 98: 184-188, 2006. (Pubitemid 43885529)
19. Macoska JA, Trybus TM and Wojno KJ: 8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer. Urology 55: 776-782, 2000.
20. Shah R, Mucci NR, Amin A, Macoska JA and Rubin MA: Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol 158: 1767-1773, 2001. (Pubitemid 32422941)
21. Yildiz-Sezer S, Verdorfer I, Schaefer G, Rogatsch H, Bartsch G and Mikuz G: Gain of chromosome X in prostatic atrophy detected by CGH and FISH analyses. Prostate 67: 433-438, 2007. (Pubitemid 46341085)
22. Sfanos KS, Wilson BA, De Marzo AM and Isaacs WB: Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proc Natl Acad Sci USA 106: 3443-3448, 2009.
23. Scarpelli M, Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L and Montironi R: Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase. Int J Immunopathol Pharmacol 25: 67-74, 2012.
24. Fradet V, Cheng I, Casey G and Witte JS: Dietary omega-3 fatty acids, cycloxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 15: 2559-1566, 2009.
25. Krieger JN, Nyberg L Jr and Nickel JC: NIH consensus definition and classification of prostatitis. JAMA 282: 236-237, 1999. (Pubitemid 29343164)
26. Magri V, Montanari E, Škerk V, et al: Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. Asian J Androl 13: 819-827, 2011.
27. Magri V, Trinchieri A, Montanari E, et al: Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection. Arch Ital Urol Androl 79: 84-92, 2007. (Pubitemid 47122189)
28. Nickel JC, True LD, Krieger JN, Berger RE, Boag AH and Young ID: Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 87: 797-805, 2001. (Pubitemid 34204319)
29. Song L, Zhu Y, Han P, Chen N, Lin D, Lai J and Wei Q: A retrospective study: correlation of histologic inflammation in biopsy specimens of Chinese men undergoing surgery for benign prostatic hyperplasia with serum prostate-specific antigen. Urology 77: 688-692, 2011.
30. De Marzo AM, Platz EA, Epstein JI, et al: A working group classification of focal prostate atrophy lesions. Am J Surg Pathol 30: 1281-1291, 2006. (Pubitemid 44454708)
31. Billis A, Meirelles L, Freitas LL, Magna LA and Ferreira U: Does the type of prostatic atrophy influence the association of extent of atrophy in needle biopsies and serum prostate-specific antigen levels? Urology 74: 1111-1115, 2009.
32. Montironi R, Mazzucchelli R, Algaba F and Lopez-Beltran A: Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance. J Clin Pathol 53: 655-665, 2000.
33. Montironi R, Scarpelli M, Mazzucchelli R, Cheng L and Lopez-Beltran A: The spectrum of morphology in non-neoplastic prostate including cancer mimics. Histopathology 60: 41-58, 2012.
34. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al: The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. J Urol 162: 369-375, 1999. (Pubitemid 29434343)
35. 2 test. J R Stat Soc 1: 217-235, 1934.
36. Billis A and Magna LA: Inflammatory atrophy of the prostate. Prevalence and significance. Arch Pathol Lab Med 127: 840-844, 2003. (Pubitemid 36792311)
37. Ruska KM, Sauvageot J and Epstein JI: Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol 22: 1073-1077, 1998. (Pubitemid 28411064)
38. McNeal JE: Normal histology of the prostate. Am J Surg Pathol 12: 619-633, 1988.
39. Srigley JR: Benign mimickers of prostatic adenocarcinoma. Mod Pathol 17: 328-348, 2004.
40. Billis A, Meirelles L and Freitas LL: Mergence of partial and complete atrophy in prostate needle biopsies: a morphologic and immunohistochemical study. Virchows Arch 456: 689-694, 2010.
41. Foundations of Clinical Research: Applications and Practice. Portney LG and Watkins MP (eds). Appleton & Lange Norwalk, Connecticut, pp509-516, 1993.